{
    "clinical_study": {
        "@rank": "136213", 
        "acronym": "EXPANDLung", 
        "arm_group": {
            "arm_group_label": "OCS Lung Tx.", 
            "arm_group_type": "Experimental"
        }, 
        "brief_summary": {
            "textblock": "To evaluate the safety and effectiveness of the OCS\u2122 Lung to recruit, preserve and assess\n      donor lungs that may not meet current standard donor lung acceptance criteria for\n      transplantation."
        }, 
        "brief_title": "International EXPAND Lung Pivotal Trial", 
        "completion_date": {
            "#text": "December 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Lung Transplant", 
        "detailed_description": {
            "textblock": "The OCS\u2122 Lung is to be used to recruit, preserve and assess donor lungs that may not meet\n      current standard donor lung acceptance criteria from one or more of the following\n      characteristics:\n\n        -  Donor PaO2/FiO2 \u2264 300 mmHg; or\n\n        -  Expected ischemic time > 6 hours; or\n\n        -  Donor after Cardiac Death (DCD donor); or\n\n        -  Donor age \u226555 years old"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  At least one of the following:\n\n               -  Donor PaO2/FiO2 \u2264 300 mmHg; or\n\n               -  Expected ischemic time > 6 hours; or\n\n               -  Donor after Cardiac Death (DCD donor); or\n\n               -  Donor age \u226555 years old\n\n        Exclusion Criteria:\n\n          -  \u2022 Presence of moderate to severe traumatic lung injury with air and/or blood leak\n\n               -  Presence of confirmed active pneumonia or persistent purulent secretions on\n                  repeated bronchoscopy evaluation or ET suction\n\n               -  Previous history of pulmonary disease\n\n               -  Multiple transfusions of >10 pRBCs units\n\n               -  ABO incompatibility\n\n               -  Tobacco history of >20 packs per year"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "75 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "75", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "September 4, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01963780", 
            "org_study_id": "OCS-LUN-012013"
        }, 
        "intervention": {
            "arm_group_label": "OCS Lung Tx.", 
            "intervention_name": "OCS Lung Preservation", 
            "intervention_type": "Device"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "lung transplantation", 
            "lung preservation", 
            "breathing lung transplant"
        ], 
        "lastchanged_date": "May 9, 2014", 
        "location": [
            {
                "contact": {
                    "email": "Michael.Smith011@DignityHealth.org", 
                    "last_name": "Michael A Smith, MD", 
                    "phone": "602-406-4000"
                }, 
                "facility": {
                    "address": {
                        "city": "Phoenix", 
                        "country": "United States", 
                        "state": "Arizona", 
                        "zip": "85013"
                    }, 
                    "name": "St. Joseph's Hospital and Medical Center"
                }, 
                "investigator": {
                    "last_name": "Michael A Smith, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "AArdehali@mednet.ucla.edu", 
                    "last_name": "Abbas Ardehali, MD", 
                    "phone": "310-825-5841"
                }, 
                "facility": {
                    "address": {
                        "city": "Los Angeles", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "90095"
                    }, 
                    "name": "University of California at Los Angeles"
                }, 
                "investigator": {
                    "last_name": "Abbas Ardehali, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "Jasleen.Kukreja@ucsfmedctr.org", 
                    "last_name": "Jasleen Kukreja, MD", 
                    "phone": "415-353-4145"
                }, 
                "facility": {
                    "address": {
                        "city": "San Francisco", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "94143"
                    }, 
                    "name": "University of California, San Francisco"
                }, 
                "investigator": {
                    "last_name": "Jasleen Kukreja, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "gloor@umn.edu", 
                    "last_name": "Gabriel Loor, MD", 
                    "phone": "612-625-4941"
                }, 
                "facility": {
                    "address": {
                        "city": "Minneapolis", 
                        "country": "United States", 
                        "state": "Minnesota", 
                        "zip": "55455"
                    }, 
                    "name": "University of Minnesota"
                }, 
                "investigator": {
                    "last_name": "Gabriel Loor, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "dirk.vanraemdonck@uzleuven.be", 
                    "last_name": "Dirk Van Raemdonck, MD, PhD", 
                    "phone": "3216346823"
                }, 
                "facility": {
                    "address": {
                        "city": "Leuven", 
                        "country": "Belgium", 
                        "zip": "3000"
                    }, 
                    "name": "University of Leuven Hospital"
                }, 
                "investigator": {
                    "last_name": "Drik Van Raemdonck, MD, PhD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "warnecke.gregor@mh-hannover.de", 
                    "last_name": "Gregor Warnecke, MD", 
                    "phone": "011495115326590"
                }, 
                "facility": {
                    "address": {
                        "city": "Hannover", 
                        "country": "Germany", 
                        "zip": "D-300625"
                    }, 
                    "name": "Hannover Medical School"
                }, 
                "investigator": {
                    "last_name": "Gregor Warnecke, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": [
                "United States", 
                "Belgium", 
                "Germany"
            ]
        }, 
        "number_of_arms": "1", 
        "official_title": "International Trial to Evaluate the Safety and Effectiveness of The Portable Organ Care System (OCS\u2122) Lung For Recruiting, Preserving and Assessing Expanded Criteria Donor Lungs for Transplantation (EXPAND Trial)", 
        "other_outcome": {
            "measure": "Incidence of Lung Graft Related Serious Adverse Events during the first 30 days post lung transplantation", 
            "safety_issue": "Yes", 
            "time_frame": "30 days"
        }, 
        "overall_contact": {
            "email": "whassanein@transmedics.com", 
            "last_name": "Waleed H Hassanein, MD", 
            "phone": "978-552-0901"
        }, 
        "overall_contact_backup": {
            "email": "tkhayal@transmedics.com", 
            "last_name": "Tamer I Khayal, MD", 
            "phone": "978-552-0901"
        }, 
        "overall_official": [
            {
                "affiliation": "University of California, Los Angeles", 
                "last_name": "Abbas Ardehali, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "University of Leuven Medical Center", 
                "last_name": "Dirk Van Raemdonck, MD, PhD", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "The COMPOSITE incidence of patient survival at day-30 post transplant and freedom of Primary Graft Dysfunction Grade 3 during the first 72 hours after lung transplantation", 
            "measure": "COMPOSITE endpoint of patient survival at Day-30 post transplant and absence of Primary Graft Dysfunction (PGD) Grade 3 during the first 72 hours post lung transplant", 
            "safety_issue": "No", 
            "time_frame": "30 days"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01963780"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Incidence of ISHLT primary graft dysfunction (PGD) Grade 2 or 3 at T72 hours post lung transplantation", 
                "safety_issue": "No", 
                "time_frame": "72 hours"
            }, 
            {
                "measure": "Incidence of Primary Graft Dysfunction Grade 3 at T72 hours", 
                "safety_issue": "No", 
                "time_frame": "72 hours"
            }
        ], 
        "source": "TransMedics", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "TransMedics", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "November 2013", 
        "study_design": "Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}